Furthermore, a selective inhibitor of TGFBRI kinase activity extends animal survival in the ALS mouse model, leading to the hypothesis that TGF-β1 may act as a negative prognostic factor, rather than a protective one [64]. This evidence concerns the gene TGFB1 and amyotrophic lateral sclerosis.